BackAprogen Biologics Overview

Aprogen Biologics Current Assets

Latest current assets for 003060.KS: $120B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$117.75B
↓ 13.25% YoYΔ $-17.98B vs prior year quarter

Peer trimmed avg / median

Loading

Aprogen Biologics Current Assets History

Loading

Aprogen Biologics vs. peers: Current Assets Comparison

Loading

Aprogen Biologics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aprogen Biologics (003060.KS) FAQ

As of the most recent data (June 2026), 003060.KS shows a current assets of $120B. That compares with $140B in the prior-year period — down 13.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 003060.KS's current assets is now $120B (was $140B) — a 13.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aprogen Biologics is outperforming or lagging.

Tracking 003060.KS's current assets over time shows whether Aprogen Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $120B That compares with $140B in the prior-year period — down 13.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Aprogen Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $120B) with ownership activity and broader fundamentals.